skip to content

Partnering

Together we can shape the future of healthcare

Decorative image
Roche signed a research collaboration and licence agreement with C4 Therapeutics (C4T)

To discover and develop degrader-antibody conjugates (DACs) targeting key cancer pathways.

Read the full story

We are passionate about advancing science – no matter where it comes from. We identify the best innovations, whether internal or external, and delivering them to patients. Only by partnering with the brightest minds in science and healthcare, can we serve patients with difficult-to-treat diseases, both now and in future.

Partnering with Pharma

Decorative illustration

>250 active global partnerships

Decorative illustration

50% of the medicines we brought to patients in the last decade were touched by a partner

Decorative illustration

140 people worldwide focused on bringing in and managing lasting partnerships

Partnering with Diagnostics

Decorative illustration

75 new agreements in 2025

Decorative illustration

24 acquisitions since 2014

Decorative illustration

+20 years of partnering with companies and research institutes globally to advance health

More about partnering with Pharma
More about partnering with Diagnostics

Areas of interest

View all areas of interest
Decorative illustration

Digital and dataInnovation

We are taking PHC toward a future where treatments are targeted to an individual’s needs and unique genetic profile.

Decorative illustration

ImmunologyInnovation

Leading the way to advance science in inflammatory and autoimmune diseases.

Decorative illustration

Infectious DiseasesInnovation

We are advancing innovation to combat infectious diseases like HBV, influenza and MDR.

Decorative illustration

NeurologyInnovation

We focus on advances for neurodegenerative, psychiatric and neurodevelopmental disorders.

Decorative image

Oncology and HaematologyInnovation

We focus on first- and best-in-class therapeutics in molecular targeted therapies and cancer immunotherapy.

Decorative illustration

OphthalmologyInnovation

We are focusing on saving people’s eyesight from the leading causes of vision loss through pioneering therapies and cutting- edge research.

Decorative illustration

Research TechnologiesInnovation

We focus on therapeutic modalities and enabling technologies.

Decorative illustration

Cardiovascular, Renal & Metabolic DiseaseInnovation

Roche is committed to making a contribution to areas of huge unmet need and societal burden through transformative science like in cardiovascular and metabolic diseases

Stories of

Partnering with Roche

See more stories of
Logo of Weil Neurohub
Series

Bridging academia and industry

Closing the gap between the bench and the clinic.

The logo for C4 Therapeutics
Series

A decade of trust looking into the future of new modalities

A partnership journey from hope and aspiration to clinical stage biotech.

An illustration showing individuals in a desert, featuring sparse vegetation and a few trees against a sandy backdrop.

Joining forces in neuroscience

Neurological disorders pose some of the greatest challenges and areas of unmet medical need. We are joining forces with others who are studying these challenges.

A person wearing a white glove holds a glass vial, showcasing careful handling of a potentially delicate substance.

Of bonds and benefits

Two made-in-Japan collaborations strengthen both Roche and its partners.

decorative image

The NT-proBNP story

Biomarkers play a crucial role in Roche’s commitment to personalised healthcare. To find them, we rely on the promising research of our external partners.

Discover more

Innovation

Driven by our passion for what we do, our autonomy in how we find solutions, and the strength of our R&D structure, we can take on the most complex challenges in healthcare.

Our teams and structure

To discover and develop the next breakthroughs, we have built a network of independent innovation engines around the world.